Pristane-induced arthritis in mice: V. Susceptibility to pristane- induced arthritis is determined by the genetic regulation of the T cell repertoire

Arthritis and Rheumatism

Volumn 41, Issue 11, 1998, Pages 2022-2031

  Wooley, Paul H ^a,b   Sud, Sudha ^a   Whalen, Janey D ^a   Nasser, Sam ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HUTZEL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; COMPLEMENTARY DNA; MAJOR HISTOCOMPATIBILITY ANTIGEN; PRISTANE; RNA; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; FLOW CYTOMETRY; GENE; GENETIC REGULATION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE;

ALLELES; ANIMALS; ANTIGENS, CD3; ARTHRITIS, RHEUMATOID; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENE REARRANGEMENT, BETA-CHAIN T-CELL ANTIGEN RECEPTOR; HYBRIDIZATION, GENETIC; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; LYMPH NODES; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED DBA; MICE, NUDE; PHENOTYPE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SYNOVIAL MEMBRANE; T-LYMPHOCYTE SUBSETS; TERPENES;

EID: 0031765854     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199811)41:11<2022::AID-ART18>3.0.CO;2-P     Document Type: Article

References (13)

1. Harris ED. Mechanisms of disease: rheumatoid arthritis-pathophysiology and implications for therapy. N Engl J Med 1990;322:1277-89.
2. Stastny P. Association of the B cell alloantigen DRw4 with rheumatoid arthritis. N Engl J Med 1978;298:869-71.
3. Emery P, Gentry KG, Mackay IR, Muirden KD, Rowley M. Deficiency of the suppressor inducer subset of T lymphocytes in rheumatoid arthritis. Arthritis Rheum 1987;30:849-56.
4. Potter M, Wax JS. Genetics of susceptibility to pristane-induced plasmacytomas in BALB/cAn: reduced susceptibility in BALB/cJ with a brief description of pristane-induced arthritis. J Immunol 1981;127:1591-5.
5. Wooley PH, Seibold JR, Whalen JD, Chapdelaine JM. Pristane-induced arthritis: the immunologic and genetic features of an experimental murine model of autoimmune disease. Arthritis Rheum 1989;32:1022-30.
6. Thompson SJ, Rook GA, Brealey RJ, van der Zee R, Elson CJ. Autoimmune reactions to heat-shock proteins in pristane-induced arthritis. Eur J Immunol 1990;20:2479-84.
7. Bedwell AE, Elson CJ, Hinton CE. Immunological involvement in the pathogenesis of pristane-induced arthritis. Scand J Immunol 1987;25:393-8.
8. Wooley PH, Whalen JD. Pristane-induced arthritis in mice. III. Lymphocyte phenotypic and functional abnormalities precede the development of pristane-induced arthritis. Cell Immunol 1991; 138:251-9.
9. McDonald AH, Degrassi A. Pristane induces an indomethacin inhibitable inflammatory influx of CD4+ T cells and IFN-γ production in plasmacytoma-susceptible BALB/cAnPt mice. Cell Immunol 1993;146:157-70.
10. Levitt NG, Fernandez-Madrid F, Wooley PH. Pristane induced arthritis in mice. IV. Immunotherapy with monoclonal antibodies directed against lymphocyte subsets. J Rheumatol 1992;19:1342-7.
11. Freund YR, Blair PB. Depression of natural killer activity and mitogen responsiveness in mice treated with pristane. J Immunol 1982;129:2826-31.
12. Chapdelaine JM, Whalen JD, Wooley PH. Pristane induced arthritis. II. Genetic regulation in F1 hybrid mice and cellular immune abnormalities following pristane injection. Autoimmunity 1991;8:215-20.
13. Wooley PH, Dillon AM, Luthra HS, Stuart JM, David CS. Genetic control of type II collagen-induced arthritis in mice: factors influencing disease susceptibility and evidence for multiple MHC-associated gene control. Transplant Proc 1983;15:180-5.